Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Embecta (EMBC) Research & Development (2020 - 2025)

Embecta's Research & Development history spans 6 years, with the latest figure at $4.6 million for Q4 2025.

  • For Q4 2025, Research & Development fell 77.34% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $21.6 million, down 72.62%, while the annual FY2025 figure was $37.3 million, 52.66% down from the prior year.
  • Research & Development for Q4 2025 was $4.6 million at Embecta, roughly flat from $4.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $23.6 million in Q3 2023 and bottomed at $4.4 million in Q2 2025.
  • The 5-year median for Research & Development is $18.0 million (2022), against an average of $16.1 million.
  • The largest annual shift saw Research & Development surged 58.04% in 2023 before it plummeted 78.43% in 2025.
  • A 5-year view of Research & Development shows it stood at $16.7 million in 2021, then grew by 1.2% to $16.9 million in 2022, then rose by 19.53% to $20.2 million in 2023, then rose by 0.5% to $20.3 million in 2024, then plummeted by 77.34% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for EMBC's Research & Development are $4.6 million (Q4 2025), $4.6 million (Q3 2025), and $4.4 million (Q2 2025).